Ticiana Leal

Dr. Ticiana Leal, a thoracic medical oncologist at the Winship Cancer Institute of Emory University, shares insights on small cell lung cancer treatment. She discusses recent breakthroughs like durvalumab approvals and immunotherapy options, emphasizing the importance of clinical trials. The conversation dives into the effectiveness of growth factors, yet points out their underutilization. Innovations in treatment methods, including the potential of novel therapies like Tarlatamab, are also highlighted, showcasing the dynamic future of lung cancer care.

Dr. Melissa Johnson from Sarah Cannon Research Institute, Dr. Ticiana Leal from Winship Cancer Institute, and Dr. Manish Patel from Florida Cancer Specialists dive into the latest advancements in lung cancer treatment. They discuss the promising role of telemedicine and palliative care, especially during the COVID pandemic. The potential of B7H3 as a treatment target is explored, alongside innovative therapies like Tarlatumab and novel drug combinations. Insights from recent clinical trials reveal exciting strategies aimed at improving patient outcomes.